Hillevax

Hillevax Debt/EBITDA

Delisted

Total Debt to EBITDA Ratio of Hillevax (HLVX) as of Nov 20, 2026.

Debt/EBITDA

0.00

Last updated:

Total Debt to EBITDA Ratio of Hillevax is 2024 0.00 . Total Debt to EBITDA Ratio of Hillevax was 2023 -0.19 . It decreases by % higher compared to the previous year.

The Hillevax Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
-1.42 USD
Jan 1, 2020
-2.32 USD
Jan 1, 2021
-2.96 USD
Jan 1, 2022
-0.23 USD
Jan 1, 2023
-0.19 USD
Jan 1, 2024
0.00 USD
The Hillevax Debt/EBITDA history
YEARDebt/EBITDAYoY
0.00-100.00%
-0.19-17.52%
-0.23-92.33%
-2.96+27.90%
-2.32+62.93%
-1.42—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Hillevax since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Hillevax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Hillevax

All Key Metrics — Hillevax